---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-002893"
form_type: "8-K"
ticker: "CBIO"
cik: "0001253689"
company_name: "CRESCENT BIOPHARMA, INC."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T02:53:19.541305+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# GlycoMimetics files updated investor presentation for Crescent Biopharma merger

## Summary
- Investor presentation for proposed merger with Crescent Biopharma updated as of January 2025.
- Presentation furnished under Regulation FD and includes proxy solicitation materials for stockholder vote.
- No new financial projections or merger consideration details disclosed in the filed exhibit.
- Supplemental to prior proxy statement filed with the SEC on April 1, 2024.
- Merger requires stockholder approval; no change to expected timeline communicated.

## SEC filing metadata
- accession: 0001104659-25-002893
- form_type: 8-K
- ticker: CBIO
- cik: 0001253689
- company_name: CRESCENT BIOPHARMA, INC.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1253689/000110465925002893/0001104659-25-002893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1253689/000110465925002893/tm253125d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-002893
- JSON: https://secwatch.observer/filing/0001104659-25-002893.json
- Plain text: https://secwatch.observer/filing/0001104659-25-002893.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.